X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18723) 18723
Publication (1927) 1927
Book Review (234) 234
Book Chapter (40) 40
Conference Proceeding (32) 32
Dissertation (15) 15
Data Set (7) 7
Government Document (6) 6
Book / eBook (3) 3
Magazine Article (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tnf-alpha (14903) 14903
index medicus (10759) 10759
humans (10555) 10555
animals (7522) 7522
male (6736) 6736
female (5432) 5432
inflammation (4564) 4564
mice (3910) 3910
cytokines (3558) 3558
immunology (3377) 3377
middle aged (3175) 3175
adult (3083) 3083
tumor-necrosis-factor (2957) 2957
tnf-α (2956) 2956
expression (2836) 2836
necrosis-factor-alpha (2658) 2658
rats (2469) 2469
tumor necrosis factor-alpha - metabolism (2285) 2285
pharmacology & pharmacy (2267) 2267
rheumatology (1996) 1996
rheumatoid-arthritis (1993) 1993
cell biology (1992) 1992
apoptosis (1902) 1902
aged (1879) 1879
nf-kappa-b (1842) 1842
tumor necrosis factor-alpha - antagonists & inhibitors (1819) 1819
infliximab (1682) 1682
activation (1649) 1649
disease models, animal (1621) 1621
biochemistry & molecular biology (1604) 1604
analysis (1500) 1500
oncology (1488) 1488
therapy (1464) 1464
research (1437) 1437
rheumatoid arthritis (1412) 1412
cells, cultured (1402) 1402
medicine, research & experimental (1311) 1311
treatment outcome (1299) 1299
cells (1289) 1289
disease (1281) 1281
tumor necrosis factor (1277) 1277
health aspects (1272) 1272
oxidative stress (1235) 1235
neurosciences (1216) 1216
tumor necrosis factor-tnf (1164) 1164
cytokines - metabolism (1152) 1152
care and treatment (1148) 1148
gene expression (1130) 1130
mice, inbred c57bl (1094) 1094
proteins (1092) 1092
tumor necrosis factor-α (1091) 1091
etanercept (1061) 1061
cancer (1060) 1060
factor-alpha (1057) 1057
in-vitro (1051) 1051
tumor necrosis factor-alpha - genetics (1051) 1051
article (1043) 1043
gene-expression (1030) 1030
medicine & public health (1021) 1021
macrophages (993) 993
research article (981) 981
antibodies, monoclonal - therapeutic use (959) 959
rodents (949) 949
arthritis (935) 935
rats, sprague-dawley (933) 933
signal transduction (916) 916
risk factors (885) 885
physiological aspects (881) 881
medicine (877) 877
enzyme-linked immunosorbent assay (858) 858
arthritis, rheumatoid - drug therapy (844) 844
gastroenterology & hepatology (838) 838
nf-kappa b - metabolism (829) 829
inhibition (827) 827
pathogenesis (796) 796
tnf alpha (789) 789
dermatology (774) 774
in-vivo (772) 772
dose-response relationship, drug (770) 770
il-6 (770) 770
surgery (763) 763
t-cells (755) 755
adolescent (749) 749
time factors (744) 744
rats, wistar (736) 736
tumor necrosis factor-alpha - immunology (730) 730
tumor necrosis factor-alpha - blood (729) 729
internal medicine (728) 728
interferon-gamma (726) 726
ifn-gamma (725) 725
tumors (713) 713
antirheumatic agents - therapeutic use (711) 711
double-blind (710) 710
adalimumab (704) 704
crohns-disease (704) 704
young adult (699) 699
cell line (692) 692
endocrinology & metabolism (686) 686
cytokine (681) 681
pathology (681) 681
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18407) 18407
German (146) 146
French (97) 97
Japanese (89) 89
Spanish (32) 32
Polish (21) 21
Russian (13) 13
Turkish (13) 13
Chinese (10) 10
Korean (9) 9
Portuguese (8) 8
Hungarian (4) 4
Dutch (3) 3
Italian (2) 2
Serbian (2) 2
Slovak (2) 2
Hebrew (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1989, Oxford medical publications., ISBN 019261715X, xvi, 297
Book
International Journal of Hyperthermia, ISSN 0265-6736, 08/2016, Volume 32, Issue 6, pp. 595 - 599
Background: Isolated limb perfusion (ILP) is an established and effective treatment for advanced melanoma and soft tissue sarcomas of the extremities with a... 
isolated limb perfusion | Advanced status | local control | rare tumours | SOFT-TISSUE SARCOMAS | COMPLETE REMISSION | EXTREMITIES | NECROSIS-FACTOR-ALPHA | T-CELL LYMPHOMA | MALIGNANT-MELANOMA | REGIONAL PERFUSION | ONCOLOGY | TNF-ALPHA | MELPHALAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Lymphoma, B-Cell - therapy | Rare Diseases - drug therapy | Carcinoma, Merkel Cell - therapy | Giant Cell Tumors - therapy | Melphalan - therapeutic use | Synovitis, Pigmented Villonodular - therapy | Carcinoma, Merkel Cell - drug therapy | Synovitis, Pigmented Villonodular - drug therapy | Fibromatosis, Aggressive - therapy | Hyperthermia, Induced | Adenomatous Polyposis Coli - therapy | Extremities | Fibromatosis, Aggressive - drug therapy | Lymphoma, B-Cell - drug therapy | Abdominal Neoplasms - therapy | Abdominal Neoplasms - drug therapy | Carcinoma, Squamous Cell - therapy | Antineoplastic Agents, Alkylating - therapeutic use | Tumor Necrosis Factor-alpha - therapeutic use | Carcinoma, Squamous Cell - drug therapy | Giant Cell Tumors - drug therapy | Rare Diseases - therapy | Perfusion | Adenomatous Polyposis Coli - drug therapy | Chemotherapy, Cancer, Regional Perfusion | necrosis-factor-alpha | melphalan | Oncology | t-cell lymphoma | Nuclear Medicine & Medical Imaging | Klinisk medicin | tnf-alpha | extremities | Clinical Medicine | carcinoma | complete remission | Radiology | soft-tissue sarcomas | malignant-melanoma | regional perfusion
Journal Article
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 03/2017, Volume 69, Issue 3, pp. 668 - 675
Journal Article
SURVEY OF OPHTHALMOLOGY, ISSN 0039-6257, 11/2015, Volume 60, Issue 6, pp. 575 - 589
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2014, Volume 73, Issue 11, pp. 1942 - 1948
Objectives To determine among patients with autoimmune diseases in the USA whether the risk of non-viral opportunistic infections (OI) was increased among new... 
DMARDs (biologic) | Infections | Tuberculosis | Rheumatoid Arthritis | TNF-alpha | RHEUMATOID-ARTHRITIS | PNEUMOCYSTIS PNEUMONIA | RISK-FACTORS | SERIOUS BACTERIAL-INFECTIONS | FACTOR-ALPHA ANTAGONISTS | GRANULOMATOUS INFECTIONS | BRITISH-SOCIETY | RHEUMATOLOGY | INFLIXIMAB | ANTIBODY THERAPY | MYCOBACTERIAL DISEASES | United States - epidemiology | Biological Therapy - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Opportunistic Infections - chemically induced | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - adverse effects | Adult | Biological Products - adverse effects | Female | Opportunistic Infections - immunology | Retrospective Studies | Autoimmune Diseases - drug therapy | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Autoimmune Diseases - epidemiology | Opportunistic Infections - epidemiology | Arthritis, Rheumatoid - epidemiology | Autoimmune Diseases - immunology | Biological Therapy - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Immunocompromised Host | Arthritis, Rheumatoid - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Complications and side effects | Care and treatment | Opportunistic infections | Tumor necrosis factor inhibitors | Dosage and administration | Autoimmune diseases | Risk factors | Codes | Bacterial infections | Medicare | Lung diseases | Inflammatory bowel disease | Immunotherapy | Pharmacy | Gangrene | Tumor necrosis factor-TNF | Medicaid | Viral infections | Pharmaceuticals
Journal Article